EASD 2025: How to Have a Happy Life in a Love/Hate Triangle of Diabetes + Pregnancy + CGM
Early Continuous Glucose Monitoring Data and Overall Glycaemic Control in Gestational Diabetes
Presenter: K. Zorko
A secondary analysis of a randomized controlled trial evaluated the relation between early (first 14 days) continuous glucose monitoring (CGM) and overall pregnancy data in gestational diabetes.
Early CGM values were strongly associated with full-pregnancy glucose trends. Higher early CGM mean glucose was associated with need for insulin therapy (p = 0.002), increased sensor scanning was correlated with lower HbA1c at baseline (p = 0.003), insulin therapy (p=0.041), lower birthrate percentile (p=0.002) and risk of large-for-gestational-age births (p = 0.005).
These findings the support the potential CGM use to guide individualized treatment and monitoring strategies for overall glycemic control in women with GDM.
EASD 2025, 15th – 19th Sept 2025, Vienna, Austria.
